why choose us

First received: August 30, 2023

Clinical Trial: Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults

Study Status: Completed

Recruit Status: RECRUITING

Condition: SARS-CoV-2 Infection

Study Type: INTERVENTIONAL


Official Title: A Phase I Study of the Safety and Immunogenicity of the Recombinant, Live-Attenuated, Bovine/Human Parainfluenza Virus Vector Vaccine Expressing the 6P-Prefusion-Stabilized Version of the SARS-Co

Brief Summary: This Phase 1 clinical trial will evaluate the safety and immunogenicity of an intranasal vaccine candidate, a recombinant, live-attenuated, bovine/human parainfluenza virus vector vaccine expressing the 6-P prefusion-stabilized version of the SARS-CoV-2 spike protein.

Read more